CME Group, CFETS Sign MOU
Partnership comes following seventh US and China strategic development dialogue.

The goal of the MOU is to develop a joint venture in the US based on the seventh US and China strategic economic dialogue. Both countries are interested in working together to explore opportunities, promote each other's market infrastructure and products via cooperation programs and help facilitate the development of both countries' markets, according to the memorandum.
"We are pleased to be able to play an active role in promoting trade and cooperation between the US and China," said Terry Duffy, executive chairman and president of CME Group, in a statement. "As China continues on its path of financial market liberalization and renminbi (RMB) internationalization, we believe that there are unique opportunities for CME Group and CFETS to work closely together to create a marketplace that best serves needs of the derivatives industry."
Currently, CFETS is China's largest marketplace for interest rates and foreign exchange products, in addition to being a major trading platform and pricing center for RMB.
"Our cooperation will bring mutual benefits to both organizations, facilitate the connectivity and opening up of financial markets of China and the US, as well as meet the demand of Sino-US economic entities to hedge their interest rates and foreign exchange risks," said Pei Chuanzhi, president of CFETS, in a statement. "At the same time, our collaboration will enable financial markets to drive economic growth, enhance the welfare of the people of both countries, and further promote international collaboration."
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
LSEG’s private funds platform, Microsoft’s new datacenter, and more
The Waters Cooler: New private markets solutions, M&A activity, and a sprinkle of DLT in this week’s news roundup.
BlueMatrix acquires FactSet’s RMS Partners platform
This is the third acquisition BlueMatrix has made this year.
Waters Wavelength Ep. 331: Cresting Wave’s Bill Murphy
Bill Murphy, Blackstone’s former CTO, joins to discuss that much-discussed MIT study on AI projects failing and factors executives should consider as the technology continues to evolves.
FactSet adds MarketAxess CP+ data, LSEG files dismissal, BNY’s new AI lab, and more
The Waters Cooler: Synthetic data for LLM training, Dora confusion, GenAI’s ‘blind spots,’ and our 9/11 remembrance in this week’s news roundup.
Chief investment officers persist with GenAI tools despite ‘blind spots’
Trading heads from JP Morgan, UBS, and M&G Investments explained why their firms were bullish on GenAI, even as “replicability and reproducibility” challenges persist.
Wall Street hesitates on synthetic data as AI push gathers steam
Deutsche Bank and JP Morgan have differing opinions on the use of synthetic data to train LLMs.
A Q&A with H2O’s tech chief on reducing GenAI noise
Timothée Consigny says the key to GenAI experimentation rests in leveraging the expertise of portfolio managers “to curate smaller and more relevant datasets.”
Etrading wins UK bond tape, R3 debuts new lab, TNS buys Radianz, and more
The Waters Cooler: The Swiss release an LLM, overnight trading strays further from reach, and the private markets frenzy continues in this week’s news roundup.